MSL
SYNH

Mackay Shields LLC’s Syneos Health, Inc. Class A Common Stock SYNH Stock Holding History

Mackay Shields LLC’s Portfolio SYNH Stock Details SYNH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q2 		– Sell
-60,421
Closed -$4.58M – 1414
2021
Q1 		$4.58M Sell
60,421
-35,477
-37% -$2.67M 0.03% 505
2020
Q4 		$6.53M Buy
95,898
+20,517
+27% +$1.28M 0.05% 416
2020
Q3 		$4.01M Buy
75,381
+32,181
+74% +$1.92M 0.03% 496
2020
Q2 		$2.52M Buy
43,200
+21,600
+100% +$1.16M 0.02% 660
2020
Q1 		$852K Sell
21,600
-53,032
-71% -$3.1M 0.01% 998
2019
Q4 		$4.44M Sell
74,632
-18,600
-20% -$1,000K 0.03% 510
2019
Q3 		$4.96M Sell
93,232
-6,900
-7% -$354K 0.03% 495
2019
Q2 		$5.12M Buy
100,132
+79,724
+391% +$3.71M 0.03% 514
2019
Q1 		$1.06M Sell
20,408
-12,875
-39% -$624K 0.01% 981
2018
Q4 		$1.31M Sell
33,283
-27,717
-45% -$1.29M 0.01% 838
2018
Q3 		$3.15M Buy
61,000
+43,400
+247% +$2.13M 0.02% 576
2018
Q2 		$825K Buy
+17,600
New +$729K 0.01% 1007

Other funds holding SYNH

Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return
Mackenzie Financial
Mackenzie Financial Toronto Ontario, Ontario, Canada $83.3B AUM 31.19% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
CB
Cooke & Bieler Philadelphia, Pennsylvania $8.84B AUM 6.92% 1-Year Est. Return

Mackay Shields LLC's SYNH Position: Q2 2021 in Review

Mackay Shields LLC sold out of Syneos Health, Inc. Class A Common Stock (SYNH) in Q2 2021, closing a stake of 60,421 shares — an estimated $4.58M sold.

Mackay Shields LLC first reported a position in SYNH in Q2 2018 and held it in 12 quarters. The position peaked at $6.53M in Q4 2020. 342 funds tracked by Wall St. Rank hold SYNH as of Q2 2021.

  • Mackay Shields LLC reported no remaining Syneos Health, Inc. Class A Common Stock position as of Q2 2021 after selling out during the quarter.
  • Mackay Shields LLC sold 60,421 Syneos Health, Inc. Class A Common Stock shares in Q2 2021, an estimated $4.58M.
  • Mackay Shields LLC first reported a position in Syneos Health, Inc. Class A Common Stock in Q2 2018 and held it in 12 quarters.
  • Mackay Shields LLC's Syneos Health, Inc. Class A Common Stock position peaked at $6.53M in Q4 2020.
  • 342 funds tracked by Wall St. Rank held Syneos Health, Inc. Class A Common Stock as of Q2 2021.

Based on Mackay Shields LLC's 13F filing for Q2 2021, filed 13 Aug 2021.